Please login to the form below

Not currently logged in
Email:
Password:

patient recruitment

This page shows the latest patient recruitment news and features for those working in and with pharma, biotech and healthcare.

FDA halts third Merck myeloma trial after patient deaths

FDA halts third Merck myeloma trial after patient deaths

FDA halts third Merck myeloma trial after patient deaths. More patients died on Keytruda combination than those on other treatments. ... Merck had previously called a halt to patient recruitment in two combination studies of Keytruda (pembrolizumab) in

Latest news

  • Harnessing the unrivalled power of key opinion leaders Harnessing the unrivalled power of key opinion leaders

    In addition to giving advice on large scale clinical trial design and patient recruitment, KOLs can help pharma tackle critical barriers to success at this point - the need to balance efficacy

  • New healthcare comms agency launched in UK New healthcare comms agency launched in UK

    The new agency offers the full spectrum of pharmaceutical marketing services - including social media and experiential marketing - with a particular expertise in clinical trial patient recruitment and retention, for which it

  • Trials of AZ's durvalumab restart as FDA hold is relaxed Trials of AZ's durvalumab restart as FDA hold is relaxed

    Patient recruitment can restart in two trials of AstraZeneca's PD-L1 inhibitor durvalumab placed under temporary suspension by the FDA, says the company. ... The phase III KESTREL trial has already re-opened for new patient enrolment at some clinical

  • ApotheCom and Continuum Clinical expand strategic partnership ApotheCom and Continuum Clinical expand strategic partnership

    The medical communications agency and patient recruitment and research company will build upon their ongoing partnership to launch a series of new market access, medical affairs and health economics and outcomes ... Chief among these will be RWE strategy

  • AstraZeneca shaken by FDA partial hold on durvalumab trial AstraZeneca shaken by FDA partial hold on durvalumab trial

    AstraZeneca shaken by FDA partial hold on durvalumab trial. Aims to resume trial recruitment as soon as possible after bleeding side effects curb study. ... that it submitted an analysis of the events to the FDA and will try to resume patient recruitment

More from news
Approximately 5 fully matching, plus 65 partially matching documents found.

Latest Intelligence

  • A quest for innovative solutions A quest for innovative solutions

    Artificial intelligence, real-world evidence and robotic and cognitive automation, to name a few, have the potential to improve study design, physician and patient recruitment and in-trial decision-making, as ... Once that is established you can generate

  • Finding the patient voice Finding the patient voice

    These statistics only give a small idea of one of the biggest problems that the pharma industry is facing - patient recruitment. ... The report successfully pinpointed four main patient profiles, those who:. Participated in a clinical trial;.

  • Patient recruitment and engagement standards Patient recruitment and engagement standards

    Patient recruitment and engagement standards. Clinical trial awareness. In the past it was absolutely crucial to do feasibility research on the clinical research sites that will run your clinical trial and ... Patient recruitment and their engagement

  • The three forces behind the re-imagining of patient care The three forces behind the re-imagining of patient care

    The three forces behind the re-imagining of patient care. Understanding patient-centricity. ... populations. Clinical trial recruitment also has the capacity to increase in speed and, at scale, exponentially increase our patient knowledge, especially in

  • Building the capabilities for a new 'patient access' model Building the capabilities for a new 'patient access' model

    facilitate that development,” says Robin Herron, patient access human resource business partner, Baxalta. ... Peter Vanovertveld is vice president, patient access, Baxalta, and is based in Northern Illinois.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

  • Anthea Davies joins Cello Health Communications Anthea Davies joins Cello Health Communications

    Meanwhile, Yates has over a decade's experience working in leading healthcare communications agencies, most recently as a patient recruitment and retention group account director at Langland, and prior to that

  • JPA adds to Washington team JPA adds to Washington team

    He joins from Matthews Media Group (MMG). As VP and senior strategist at MMG, Goldfarb developed communications plans and ran patient recruitment initiatives of clinical trials.

  • Ketchum names new global healthcare practice director

    Her role will involve collaborating with senior counsellors and leaders from Ketchum's other practices and specialty areas, including clinical trial patient recruitment firm MMG, medical education group Inspired Science and ... Sefton has 15 years'

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

The Holy Grail of HCP Access
This is the data you need to gain access....
No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....

Infographics